Management of hepatocellular carcinoma | ||||
| African Journal of Gastroenterology and Hepatology | ||||
| Editorial, Volume 4, Issue 1, July 2021, Page 19-25 PDF (377.18 K) | ||||
| DOI: 10.52378/mhae1978 | ||||
 View on SCiNiTO | ||||
| Author | ||||
Salem Youssef Mohamed  
| ||||
| Internal Medicine department, gastroenterology, and hepatology, faculty of medicine, Zagazig University, Egypt | ||||
| Abstract | ||||
| Hepatocellular carcinoma (HCC) is a heterogeneous disease that develops most of the time in the diseased liver. Early diagnosis and management are the best options for patients, so screening programs are mandatory for those at risk of developing HCC. Despite the challenges of management of HCC, there is hopeful management for HCC as the field of primary liver cancer has moved quickly. | ||||
| Keywords | ||||
| hepatocellular carcinoma; management; epidemiology; immune checkpoint inhibitors | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 294 PDF Download: 196 |
||||
